Countries opting for self-procurement should only use Gavi funds to purchase vaccines and related injection safety devices (auto-disable syringes and disposal boxes) that meet international quality standards.
Countries receiving Gavi’s new vaccine support have the following two options for the procurement of vaccines and vaccine devices:
Countries that prefer to self-procure vaccines using Gavi support must assure that international expectations of assured quality are met. Self-procured vaccines must either:
Unsafe injections represent a well-established risk and there are no widely-applied national quality assurance mechanisms for these supplies, in the same way as there are NRAs for vaccines. Countries using Gavi funds to self-procure auto-disable syringes are required to procure products, which are pre-qualified under WHO’s Performance, Quality and Safety system.
For syringe and needle disposal boxes, countries self-procuring with Gavi funds must either:
In addition to the application process and information regarding quality assurance, here are two important steps for a country to self-procure using Gavi funds:
Vaccines self-procured by countries as part of their co-financing obligation are beyond the scope of this policy. However, Gavi strongly encourages countries self-procuring co-financed vaccines and injection safety devices to ensure they are of WHO-defined assured quality, such as those on the WHO list of pre-qualified products or as otherwise described above and that the programmatic suitability of the product has been considered.
For additional information on quality assurance for self-procuring countries, click here.
The self-procurement policy was approved by the Gavi Board in June 2016. It formalised the existing guidelines on self-procurement as discussed by the Programme and Policy Committee in 2012. It will be reviewed at the request of the Board.Information on programmatic suitability on WHO website